Skip to content

Alamar Biosciences

US · ALMR #2657 by market cap Listed 2026
26.48 -2.20 -7.67%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:30

Recent news

  • Rating change
    Analysts Offer Insights on NA Companies: Alamar Biosciences, Inc. (ALMR), NIQ Global Intelligence PLC (NIQ) and Amentum Holdings, Inc. (AMTM)
    TipRanks · 2026/8/11
  • Rating change
    Analysts Are Bullish on Top NA Stocks: Alamar Biosciences, Inc. (ALMR), Seaport Therapeutics, Inc. (SPTX)
    TipRanks · 2026/6/9
  • Rating change
    Analysts Offer Insights on NA Companies: AEVEX Corp. Class A (AVEX) and Alamar Biosciences, Inc. (ALMR)
    TipRanks · 2026/5/12
  • Rating change
    Leerink Partners Initiates Alamar Biosciences(ALMR.US) With Buy Rating, Announces Target Price $35
    Market Newswire · 2026/5/13
  • Alamar Biosciences(ALMR.US) 10% Shareholder Sells US$5.97 Million in Common Stock
    Market Newswire · 2026/10/30
  • Rating change
    A Quick Look at Today's Ratings for Alamar Biosciences(ALMR.US), With a Forecast Between $27 to $35
    Market Newswire · 2026/5/12
  • Rating change
    J.P. Morgan Maintains Alamar Biosciences(ALMR.US) With Buy Rating, Raises Target Price to $32
    Market Newswire · 2026/7/22
  • Rating change
    Stifel Maintains Alamar Biosciences(ALMR.US) With Buy Rating, Raises Target Price to $32
    Market Newswire · 2026/8/11
  • Rating change
    J.P. Morgan Maintains Alamar Biosciences(ALMR.US) With Buy Rating, Raises Target Price to $35
    Market Newswire · 2026/8/11
  • Alamar Biosciences(ALMR.US) 10% Shareholder Sells US$5.68 Million in Common Stock
    Market Newswire · 2026/11/4
  • Rating change
    Stifel Maintains Alamar Biosciences(ALMR.US) With Buy Rating, Maintains Target Price $28
    Market Newswire · 2026/6/9
  • TD Cowen Maintains Alamar Biosciences(ALMR.US) With Buy Rating, Raises Target Price to $36
    Market Newswire · 2026/11/4
  • BofA Securities Maintains Alamar Biosciences(ALMR.US) With Hold Rating
    Market Newswire · 2026/11/5
  • Alamar Biosciences(ALMR.US) 10% Shareholder Sells US$3.33 Million in Common Stock
    Market Newswire · 2026/11/6
  • Rating change
    Analysts Offer Insights on NA Companies: Alamar Biosciences, Inc. (ALMR), NIQ Global Intelligence PLC (NIQ) and ServiceTitan, Inc. Class A (TTAN)
    TipRanks · 2026/8/11
  • Rating change
    BofA Securities Maintains Alamar Biosciences(ALMR.US) With Hold Rating, Raises Target Price to $31
    Market Newswire · 2026/8/11
  • Rating change
    TD Cowen Maintains Alamar Biosciences(ALMR.US) With Buy Rating, Raises Target Price to $34
    Market Newswire · 2026/7/15
  • Alamar Biosciences(ALMR.US) 10% Shareholder Sells US$8.57 Million in Common Stock
    Market Newswire · 2026/10/28
  • Alamar Biosciences(ALMR.US) 10% Shareholder Sells US$4.82 Million in Common Stock
    Market Newswire · 2026/10/20
  • Alamar Biosciences(ALMR.US) 10% Shareholder Sells US$5.95 Million in Common Stock
    Market Newswire · 2026/10/22
  • Alamar Biosciences(ALMR.US) 10% Shareholder Sells US$10.25 Million in Common Stock
    Market Newswire · 2026/10/24
  • Form 144 | Alamar Biosciences(ALMR.US) Insider Proposes to Sell 8.56 Million in Common Stocks
    Market Newswire · 2026/10/15
  • Form 144 | Alamar Biosciences(ALMR.US) Insider Proposes to Sell 10.24 Million in Common Stocks
    Market Newswire · 2026/10/15
  • Form 144 | Alamar Biosciences(ALMR.US) Insider Proposes to Sell 36.66 Million in Common Stocks
    Market Newswire · 2026/10/15

Headlines are aggregated automatically and are not independently verified or edited by our team.

Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.

Alamar Biosciences discussion 0 comments

Add a comment